Funding

Dr. Patel receives funding for her infectious diseases research from the National Science Foundation, the Department of Defense, Paratek, and other generous benefactors.

Investigator & Role Grant Title Funding Source Duration
Robin Patel, Ph.D., principal investigator IND enabling development of CF-296, a lysin for the treatment of invasive Staphylococcus aureus infections U.S. Department of Defense 02/01/2019–02/01/2020

  • Gary M. Dunny, Ph.D. (UMN), principal investigator

  • Robin Patel, M.D., consortium principal investigator

  • Purna C. Kashyap, MBBS, co-investigator

 Functional genomics analysis of colonization and persistence of Enterococcus faecalis in the gastrointestinal tract National Institutes of Health 02/01/2017–01/31/2019

  • Robin Patel, M.D., principal investigator

  • Nicholas Chia, Ph.D., co-investigator

 Metagenomic analysis of arthroplasty failure National Institutes of Health 04/01/2015–03/31/2019

  • Robin Patel, M.D., principal investigator

  • Cassandra Brinkman, Ph.D., co-investigator

 Disappearance of rifampin resistance in MRSA foreign body osteomyelitis National Institutes of Health 06/01/2016–05/31/2019

  • Robin Patel, M.D., principal investigator

  • Linda Williams, Ph.D., co-investigator

 Antibacterial clay effects on pathogenic bacteria National Science Foundation 04/01/2017–03/31/2019

  • Gary M. Dunny, Ph.D. (UMN), principal investigator

  • Robin Patel, M.D., Consortium principal director, principal investigator

  • Purna C. Kashyap, MBBS, co-investigator

 Enterococcal sex pheromones: Impact on antibiotic resistance transfer and ecology of the gastrointestinal tract National Institutes of Health 06/01/2017–05/31/2019
Robin Patel, M.D., principal investigator Cardiovascular implantable electronic device infection — molecular approach to diagnosis Mayo Clinic CCaTS 01/01/2018–12/31/2018

  • Robin Patel, M.D., principal investigator

  • Nicholas Chia, Ph.D., co-investigator

 Metagenomic shotgun sequencing of blood to identify pathogens in patients with neutropenic fever Mayo Clinic CIM Microbiome Program 07/01/2017–12/1/2018
Robin Patel, M.D., principal investigator Activity of Lysin 301 in methicillin-resistant Staphylococcus aureus osteomyelitis U.S. Department of Defense 01/01/2018–12/31/2018
Robin Patel, M.D., principal investigator Activity of omadacycline in methicillin-resistant Staphylococcus aureus osteomyelitis Paratek 03/19/2018–03/18/2019

  • Valerie Pierre, Ph.D. (UMN), principal investigator

  • Henry L. Wong, Ph.D. (UMN), co-investigator

  • Timothy R. DeGrado, Ph.D., co-principal investigator

  • Robin Patel, M.D., co-investigator

 PET agents for in vivo imaging of bacterial infections Minnesota Partnership 02/01/2018–02/01/2020

  • Vincent Rotello, Ph.D. (UMass), principal investigator

  • Robin Patel, M.D., principal investigator

 Cross-linked nanosponges for the topical treatment of wound biofilms National Institutes of Health 07/24/2018–06/30/2022